Does BPC-157 have any human trials?
Yes, five small ones as of the FDA's July 2026 review, with fewer than 110 people in total. They are a 53-patient study in ulcerative colitis (a bowel disease), a Croatian early safety study, and three US clinic reports with no comparison group, on knee pain, bladder pain (interstitial cystitis), and giving it through a vein. Two of the five were only published as short conference summaries. No study has run longer than two weeks, or used the shots under the skin or pills most buyers actually use.
Studies in people from the compound pages this answer belongs to
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of healing and recovery peptides. BPC-157, TB-500, GHK-Cu, and the tissue repair family, including what actually has human data.